Alkermes PLC header image

Alkermes PLC

ALKS

Equity

ISIN IE00B56GVS15 / Valor 13920929

NASDAQ (2026-10-27)
USD 44.32-0.27%

Alkermes PLC
UMushroom community rating:

star star star star star
0.00 0 votes No rating yet
NegativeNeutralPositive

About company

Alkermes PLC is a biopharmaceutical company focused on the development and commercialization of medicines for the treatment of psychiatric and neurological disorders, areas known for their complexity and the significant challenges they pose in treatment. Leveraging its deep expertise in neuroscience, Alkermes aims to address the unmet needs of patients suffering from conditions that are often difficult to treat and historically subject to stigma. The company's portfolio includes both marketed medicines and investigational drugs that are currently in various stages of clinical development. Alkermes emphasizes a patient-centric approach in its research and development efforts, striving to innovate in fields where therapeutic options are limited or inadequate. Through its integrated research strategy and specialized commercial infrastructure, Alkermes is committed to delivering new treatment options that can potentially transform the management of psychiatric and neurological diseases, underscoring its dedication to making a meaningful difference in patients' lives.

Summarized from source with an LLMView SourceSector: Healthcare

Latest Results ():

Summarized from source with an LLMView Source

Key figures

49.1%1Y
85.4%3Y
54.7%5Y

Performance

40.3%1Y
38.2%3Y
38.1%5Y

Volatility

Market cap

7435 M

Market cap (USD)

Daily traded volume (Shares)

1,322,009

Daily traded volume (Shares)

1 day high/low

29.42 / 28.78

1 day high/low (USD)

52 weeks high/low

0.00 / 0.00

52 weeks high/low (USD)

Dividend ex-date

01 January, 2022

Dividend ex-date

Dividend

0.00

Dividend (USD)

Dividend yield (p.a.)

0.00%

Dividend yield (p.a.)

0.002022
0.002023
0.002024

Est dividend (USD)

0.00%2022
0.00%2023
0.00%2024

Est dividend yield

P/E ratio

10.00

P/E ratio

00.002022
00.002023
00.002024

Est P/E ratio

EPS

0.00

EPS (USD)

0.002022
0.002023
0.002024

Est EPS (USD)

Ratings & reviews

star star star star star

0.00

0 votes
Performance:
starstarstarstarstar
0.00
Innovation:
starstarstarstarstar
0.00
Society:
starstarstarstarstar
0.00
Nature:
starstarstarstarstar
0.00

EQUITIES OF THE SAME SECTOR

LeMaitre Vascular inc
LeMaitre Vascular inc LeMaitre Vascular inc Valor: 2755054
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
-0.62%USD 83.79
Janux Therapeutics Inc
Janux Therapeutics Inc Janux Therapeutics Inc Valor: 111742522
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
3.42%USD 17.26
BACHEM HOLDING LTD
BACHEM HOLDING LTD BACHEM HOLDING LTD Valor: 117649372
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
0.60%CHF 83.35
Tecan Group Ltd.
Tecan Group Ltd. Tecan Group Ltd. Valor: 1210019
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
0.16%CHF 243.00
Align Technology Inc
Align Technology Inc Align Technology Inc Valor: 1159441
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
-0.20%USD 151.95
Tempus AI Inc
Tempus AI Inc Tempus AI Inc Valor: 135855934
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
7.43%USD 72.15
Lineage Inc
Lineage Inc Lineage Inc Valor: 136372357
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
-1.03%USD 35.38
BrightSpring Health Services Inc
BrightSpring Health Services Inc BrightSpring Health Services Inc Valor: 131996976
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
-0.88%USD 58.36
Humana Inc
Humana Inc Humana Inc Valor: 940174
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
-0.57%USD 414.85
Healthcare Services Group Inc
Healthcare Services Group Inc Healthcare Services Group Inc Valor: 938239
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
-2.99%USD 24.37